We offer a B2B database with 18 years of experience, designed to help you connect with key decision-makers, expand your business network, and drive lead generation, email marketing, recruitment, customer acquisition, and sales growth, marketing, driving business growth. Our Specialties Include: 🟢 over 284 million contact leads, and 75.1 million company profiles across 148 industries in 202 countries. 🟢 Comprehensive Contact Details: Includes business/personal emails, full names, job titles, departments, and phone numbers. 🟢 Company Information: Detailed profiles with company names, addresses, industry, revenue, employee size, and LinkedIn URLs. 🟢 5.2 Million+ Researchers: Connect with professionals at all levels, from entry-level to C-suite, driving innovation across various fields. 🟢 Real-Time Data: Over 1 million updates per hour, ensuring continuous data accuracy and relevancy. 🟢 Global Biotech and Pharma Researchers and Business Executives Database
External link for SCIDATA
India , kerala
INDIA, Kerala, IN
"A well-curated B2B database is not just a resource; it's the foundation of informed decisions, targeted strategies, and sustainable business growth." #B2BDatabase #LeadGeneration #Sales #Marketing #BusinessGrowth #CustomerAcquisition #Networking #PrecisionData #BusinessSuccess
This content isn’t available here
Access this content and more in the LinkedIn app
Unlock business success with our precise B2B database solutions! From lead generation to customer acquisition, we empower your sales, marketing, and networking efforts to drive growth. Request a free sample today! #B2BDatabase #LeadGeneration #BusinessGrowth
Precision in your database is a key factor for success in business. Struggling with building a strong business network, lead generation, customer acquisition, sales, or marketing? We’re here to help! Our B2B database solutions are designed to help you achieve these goals and drive growth. Interested in exploring our database? Reach out for a sample! #B2BDatabase #LeadGeneration #Sales #Marketing #BusinessGrowth #CustomerAcquisition #Networking #PrecisionData #BusinessSuccess
Ready to turn emails into opportunities? Email marketing is your secret weapon for building connections, boosting sales, and keeping your audience engaged with personalized and impactful campaigns.🔉 #emailmarketing #marketingdubai #marketingmadeeasy #uaecampaigns
Precision in your database is a key factor for success in business. Struggling with building a strong business network, lead generation, customer acquisition, sales, or marketing? We’re here to help! Our B2B database solutions are designed to help you achieve these goals and drive growth. Interested in exploring our database? Reach out for a sample! #B2BDatabase #LeadGeneration #Sales #Marketing #BusinessGrowth #CustomerAcquisition #Networking #PrecisionData #BusinessSuccess
Precision in your database is a key factor for success in business. Struggling with building a strong business network, lead generation, customer acquisition, sales, or marketing? We’re here to help! Our B2B database solutions are designed to help you achieve these goals and drive growth. Interested in exploring our database? Reach out for a sample! #B2BDatabase #LeadGeneration #Sales #Marketing #BusinessGrowth #CustomerAcquisition #Networking #PrecisionData #BusinessSuccess
SCIDATA reposted this
Co-Founder @ BiopharmIQ - Bio/Pharma data for business development and investors. Helping biotech sales/BD teams uncover more potential partners utilizing data.
Phase 2 & 3 Data Readouts Left This Quarter.. Here's a few of the biggest to watch 👇 UroGen Pharma - Phase 3 data from ENVISION study Viking Therapeutics, Inc. - Phase 2b data from VOYAGE study. Lipocine Inc. - Topline results from pivotal PK study. See table below for ph 2 & 3 readouts this quarter. --- 👋 I'm Dominic Vacchiano, Co-founder of BiopharmIQ by Amp. We provide biopharma data to help with your BD/investing activities. 📰 Each week we share clinical/regulatory/funding news in an easy-to-digest format. #biotech #biopharma
SCIDATA reposted this
Co-Founder @ BiopharmIQ - Bio/Pharma data for business development and investors. Helping biotech sales/BD teams uncover more potential partners utilizing data.
Biopharma Funding Activity May 20th-24th ‘24 2 newly launched companies and more funding events… Get these weekly → https://lnkd.in/gDdkUYb3 – 𝐏𝐫𝐢𝐯𝐚𝐭𝐞 𝐅𝐮𝐧𝐝𝐢𝐧𝐠 – AltruBio Inc. 💸 Received an oversubscribed Series B financing of up to $225M led by BVF Partners LP, and other investors to support ongoing and planned Phase 2a and 2b clinical trials of immune checkpoint enhancer, ALTB-268, in ulcerative colitis. Pheon Therapeutics 💸 Completed a $120m Series B financing led by TCGX, with participation from BVF Partners and other investors. The funding will be used to further advance Pheon's differentiated ADC pipeline through clinical proof of concept for its first three assets in a wide range of solid tumors. SixPeaks Bio 💸 Launched with $110M funding: $30M in Series A led by Versant Ventures and $80M non-dilutive financing from AstraZeneca. 𝐏𝐫𝐨𝐠𝐞𝐧𝐭𝐨𝐬 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 💸 Launched with $65M Series A financing led by Forbion to advance its multiple sclerosis program. Aktis Oncology 💸 Received $60M upfront cash payment for the collaboration in addition to an equity investment in Aktis by Lilly to generate novel tumor-targeting radiopharmaceuticals. – 𝐏𝐨𝐬𝐭-𝐈𝐏𝐎/𝐏𝐮𝐛𝐥𝐢𝐜 𝐅𝐮𝐧𝐝𝐢𝐧𝐠 – Bicycle Therapeutics 🏦 Announced $555M private investment in public equity. Cytokinetics 🏦 Announced pricing of $500M stock offering. Dyne Therapeutics 🏦 Announced pricing of $325.5M public offering. Erasca, Inc. 🏦 Announced closing of $184M offering. Foghorn Therapeutics Inc. 🏦 Announced pricing of $110M direct offering and pre-funded warrants. --- 👋 I'm Dominic Vacchiano, Co-founder of BiopharmIQ by Amp. We provide biopharma data to help with your sales/BD activities. 📰 Each week we share clinical/regulatory/funding news in an easy-to-digest format. #biotech #biopharma
SCIDATA reposted this
Why Are Some Images Are More Memorable Than Others? A new study reveals why some images are more memorable: the brain prioritizes harder-to-explain scenes. Findings could improve AI memory systems.